Skip to main content
. 2021 Nov 28;26(23):7216. doi: 10.3390/molecules26237216

Table 4.

Efficacy of cannabinoids against virus proliferation.

Virus Compound Activity (µM) Ref
Epstein–Barr virus (EBV) THC IC50 3.0 [140]
Hepatitis C virus (HCV) CBD EC50 3.16 [143]
Herpes simplex virus (HSV) THC IC50 1.9 [140]
Kaposi sarcoma associated herpesvirus (KSHV) THC IC50 3.3 [140]
KSHV CBD IC50 2.08 [144]
Murine gamma herpesvirus 68 (MHV) THC IC50 1.9 [140]